Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis
Conclusions:
Current literature suggests insufficient accuracy of endoscopic biopsies, EUS, and 18F-FDG PET(-CT) as single modalities for detecting residual disease after nCRT for esophageal cancer.
Source: Annals of Surgery - Category: Surgery Tags: META-ANALYSES Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Science | Skin Cancer | Squamous Cell Carcinoma | Study | Surgery